Skip to Content

WPI 3248 (Valacyclovir Hydrochloride 500 mg)

Pill with imprint WPI 3248 is Blue, Capsule-shape and has been identified as Valacyclovir Hydrochloride 500 mg. It is supplied by Watson Laboratories, Inc..

Valacyclovir is used in the treatment of cold sores; herpes simplex; herpes simplex, suppression; herpes simplex, mucocutaneous/immunocompetent host; cmv prophylaxis and belongs to the drug class purine nucleosides. There is no proven risk in humans during pregnancy. Valacyclovir 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 3248

Valacyclovir hydrochloride 500 mg WPI 3248
Valacyclovir hydrochloride 500 mg WPI 3248
Valacyclovir hydrochloride 500 mg WPI 3248
Valacyclovir hydrochloride 500 mg WPI 3248

Valacyclovir Hydrochloride

Imprint
WPI 3248
Strength
500 mg
Color
Blue
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Purine nucleosides
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
00591-3248
Inactive Ingredients
croscarmellose sodium, FD&C Blue No. 2, hydrogenated castor oil, hypromelloses, polyethylene glycol, polysorbate 80, corn starch, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.